Targeted therapies represent a significant paradigm shift in the treatment of cancer. By focusing on specific molecular abnormalities in cancer cells, these therapies offer a customized approach to cancer treatment. This specificity not only increases the effectiveness of the treatment but also reduces the severity of side effects compared to traditional approaches.

The future of cancer treatment lies in the continued development and refinement of targeted therapies, which promises more personalized and effective care for cancer patients. Ongoing research and clinical trials are crucial for advancing our understanding and application of these innovative therapies.